TITLE

Mortality Rate and Risk Factors in Patients With Hereditary Pancreatitis: Uni- and Multidimensional Analyses

AUTHOR(S)
Rebours, Vinciane; Boutron-Ruault, Marie-Christine; Jooste, Valérie; Bouvier, Anne-Marie; Hammel, Pascal; Ruszniewski, Philippe; Lévy, Philippe
PUB. DATE
September 2009
SOURCE
American Journal of Gastroenterology;Sep2009, Vol. 104 Issue 9, p2312
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVES:Patients with hereditary pancreatitis (HP) bear a high risk of pancreatic adenocarcinoma, but their life expectancy remains unknown. The objective of the study was to assess whether the high risk of cancer decreases survival.METHODS:Inclusion criteria were the presence of a PRSS1 mutation with pancreatic symptoms or chronic pancreatitis in at least two first-degree relatives or three second-degree relatives without another cause. Survival rates were assessed according to risk factors. Excess mortality compared with the general French population was calculated (statistical Esteve model) for two periods (20–50 and 50–70 years), according to several risk factors.RESULTS:The cohort comprised 189 patients. PRSS1 mutations were found in 66%. A total of 19 patients died at the median age of 60. In all, 10 deaths were attributable to HP, including 8 to pancreatic adenocarcinoma. Median overall survival for the whole cohort was 74 years (95% confidence interval (CI): 71–79). The presence of R122H mutation, gender, tobacco consumption in patients older than 18 years, and diabetes mellitus were not associated with differences in survival. Only patients with pancreatic cancer had decreased survival (P=0.008). Excess mortality risk compared with the general population was 0.02% between 20 and 50 years, and 0.61% between 50 and 70 years (NS). Gender, R122H mutation, diabetes, and tobacco use were not associated with excess mortality in these two periods.CONCLUSIONS:Despite their high risk of cancer, HP patients do not have excess mortality risk compared with the general population, irrespective of gender, tobacco use, or diabetes mellitus. These data should be brought to the patient's attention.
ACCESSION #
44012431

 

Related Articles

  • Predicting Life Expectancy in Patients With Prostate Cancer. Saad, Fred; Geldres, Claudio // AUANews;May2008, Vol. 13 Issue 5, p8 

    The article focuses on the accuracy of clinicians' prediction of the life expectancy (LE) in prostate cancer patients. Tools such as life tables and comorbidity indices help clinicians predict patients' LE. The Charlson comorbidity index (CCI), the most widely used in medical literature, is a...

  • Radiation dose and cancer risk to children undergoing skull radiography. Michael Mazonakis; John Damilakis; Maria Raissaki; Nicholas Gourtsoyiannis // Pediatric Radiology;Aug2004, Vol. 34 Issue 8, p624 

    Background: Limited data exist in the literature concerning the patient-effective dose from paediatric skull radiography. No information has been provided regarding organ doses, patient dose during PA skull projection, risk of cancer induction and dose to comforters, i.e. individuals supporting...

  • Life expectancy of colon, breast, and testicular cancer patients: an analysis of US-SEER population-based data. Capocaccia, R.; Gatta, G.; Dal Maso, L. // Annals of Oncology;Jun2015, Vol. 26 Issue 6, p1263 

    Background: Cancer survivorship is an increasingly important issue in cancer control. Life expectancy of patients diagnosed with breast, colon, and testicular cancers, stratified by age at diagnosis and time since diagnosis, is provided as an indicator to evaluate future mortality risks and...

  • UK ranks among lowest in Europe on cervical cancer survival. Dobson, Roger // BMJ: British Medical Journal (International Edition);4/14/2007, Vol. 334 Issue 7597, p764 

    This article reports on a new study which shows that rates of survival for cervical cancer patients in the UK are among the lowest in Europe. The study, which was published in "Gynecologic Oncology," was based on data from more than 70,000 women in 18 countries. Survival in Europe overall has...

  • Modeling Disease Elimination. Somerville, Kevin; Francombe, Paula // Journal of Insurance Medicine;2005, Vol. 37 Issue 1, p13 

    The effect of the elimination of mortality from heart disease and cancer was modelled mathematically to allow for the effect of other competing causes of death. The model allows for potential dependence between heart disease or cancer and other causes of death by using cupola functions, which...

  • Review: Enteral or parenteral nutrition reduces risk for mortality in acute pancreatitis. Sultan, Shahnaz; Forsmark, Chris E. // ACP Journal Club;12/16/2008, Vol. 149 Issue 6, p4 

    The article offers information on a research regarding mortality risks in patients with acute pancreatitis provided with enteral or parenteral nutrition. Studies selected compared standard enteral or parenteral nutrition with no supplementary nutrition or enteral nutrition with parenteral...

  • Cultural beliefs and values in cancer patients. Daher, M. // Annals of Oncology;May2012 Supplement 3, Vol. 23 Issue suppl_3, p66 

    In 2008, the International Agency for Research on Cancer (IARC) released its World Cancer Report, which indicated that cancer accounts for approximately 12% of all-cause mortality worldwide. IARC estimated that globally 7.6 million peopled died from cancer and that 12.4 million new cases were...

  • Person-Years of Life Lost Due to Cancer in the United States, 1970 and 1984. Horm, John W.; Sondik, Edward J. // American Journal of Public Health;Nov89, Vol. 79 Issue 11, p1490 

    Abstract: The number of deaths due to cancer in the United States reached an all-time high of 453,450 deaths in 1984 and, due to the dynamics of population growth, will continue to increase if the risk of dying from cancer does not change. Between 1970 and 1984, the total Person-Years of Life...

  • A Model-Based Estimate of Cumulative Excess Mortality in Survivors of Childhood Cancer. Yeh, Jennifer M.; Nekhlyudov, Larissa; Goldie, Sue J.; Mertens, Ann C.; Diller, Lisa // Annals of Internal Medicine;4/6/2010, Vol. 152 Issue 7, p409 

    Background: Although childhood cancer survival rates have dramatically increased, survivors face elevated risk for life-threatening late effects, including secondary cancer. Objective: To estimate the cumulative effect of disease- and treatment-related mortality risks on survivor life...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics